Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

Supervised HIIT and CME combined with resistance training significantly improved physical function in older patients with HIV.

Joshua Richter, MD, and Roy Beveridge, MD, explain the role triplet regimens play in MM treatment and how physician decision-making has been impacted since the NCCN guidelines have expanded the list ...

Please provide your email address to receive an email when new articles are posted on . Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard ...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced that the European ...

Panelists discuss how future AML treatment will likely involve sophisticated decisions about triplet combinations, optimal sequencing of targeted agents, and balancing efficacy with toxicity through ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

In the search for shorter, effective, and safe regimens to treat fluoroquinolone-susceptible, rifampin-resistant tuberculosis (TB), three 9-month regimens incorporating newer and repurposed drugs ...

The researchers found that 80.7% of the patients in the standard-therapy group had favorable outcomes in the modified intention-to-treat analysis. (HealthDay News) — Three all-oral shortened regimens ...

Violet Chihota is a member of the South African National TB Think Tank. Tuberculosis (TB) is a major cause of illness and death around the world. In 2019, 10 million people fell ill with TB and close ...

"Time has stood still" for many who've been on complex regimens for decades ...